NEW YORK (GenomeWeb News) – Warnex has signed up Biron Laboratoire medical, a diagnostic and medical services provider in Quebec, to distribute its test for influenza A H1N1, Warnex said yesterday.

Warnex said Biron, which operates more than 100 sites throughout Quebec, will promote and distribute the test and will specifically target industrial companies as customers.

The Warnex test uses RT-PCR to detect the A H1N1 strain in as little as eight hours, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.